(Q36903081)

17 August 2017

title

Schnitzler's syndrome: successful treatment with anakinra (English)

1 reference

17 August 2017

Rohan Crouch

1

1 reference

17 August 2017

Victoria Akhras

series ordinal

2

1 reference

17 August 2017

Robert Sarkany

series ordinal

3

1 reference

17 August 2017

publication date

1 August 2007

1 reference

Australasian Journal of Dermatology

17 August 2017

published in

1 reference

17 August 2017

volume

48

1 reference

17 August 2017

issue

3

1 reference

17 August 2017

page(s)

178-181

1 reference

Schnitzler's syndrome: report of a case with progression to Waldenström's macroglobulinaemia

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00375.X

Beneficial response to anakinra and thalidomide in Schnitzler's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00375.X

Report of a case of Schnitzler's syndrome treated successfully with interferon alpha 2b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00375.X

Anti-interleukin-1α autoantibodies in humans: Characterization, isotype distribution, and receptor-binding inhibition—Higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00375.X

Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00375.X

Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2007.00375.X

10.1111/J.1440-0960.2007.00375.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference